{
    "Trade/Device Name(s)": [
        "QUANTA Flash\u00ae Jo-1",
        "QUANTA Flash\u00ae Jo-1 Calibrators",
        "QUANTA Flash\u00ae Jo-1 Controls"
    ],
    "Submitter Information": "INOVA Diagnostics, Inc.",
    "510(k) Number": "K151429",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053653"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LLL",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "January 14, 2016",
    "Summary Letter Received Date": "January 15, 2016",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Antinuclear Antibodies Immunological Test System",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG anti-Jo-1 antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Barcode labeled tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BIO-FLASH\u00ae instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)",
        "Solid phase immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Flash Jo-1 chemiluminescent immunoassay and associated calibrators and controls for detection of IgG anti-Jo-1 antibodies in human serum as aid in diagnosis of idiopathic inflammatory myopathy",
    "Indications for Use Summary": "Semi-quantitative determination of IgG anti-Jo-1 antibodies in human serum to aid in the diagnosis of idiopathic inflammatory myopathy, intended for use in conjunction with clinical findings and other laboratory tests",
    "fda_folder": "Immunology"
}